LYTIR

Company · TMDX

TransMedics Group, Inc.

Nasdaq's symbol directory lists TMDX on Nasdaq as “TransMedics Group, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 1 occasion ($109K); insiders sold on 1 occasion ($722K); 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $109K in total; Insider sales: $722K in total.Jun: Insider sales $722KSep: Insider purchases $109KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $109KInsider sales below: $722K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Gunderson Thomas J. sold on 1 day latest Jun 15, 2026 sold $722K
  2. Weill David bought on 1 day latest Sep 11, 2026 bought $109K
Every trade (2)
  1. BUYWeill David bought Sep 11, 2026 1,336 shares filing $109K
  2. SELLGunderson Thomas J. sold Jun 15, 2026 9,624 shares filing $722K

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 5, 2026
  2. Departure or appointment of directors or officers; Regulation FD disclosure filing Sep 10, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.